Latest news: Another Alzheimer's 'breakthrough'?; GSK decamps from iconic HQ; Red light in off-the-shelf CAR-T; Charting biotech's Q3; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
R&D strategies are central to any biopharma company — and especially the larger ones. John Carroll has invited a stellar slate of guests to talk about exactly that at the European Biopharma Summit coming up next week. You can view the line up and reserve a spot here.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 120,700+ biopharma pros reading Endpoints daily — and it's free.